• Courtesy of Simon Villalba, MD-Clinica Barraquer Centro Oftamologico Bogota, Colombia; Julibeth Alvarez, MD-Beraja Medical Institute, Coral Gables, FL USA; Juan P. Fernandez de Catro, MD, Beraja Medical Institute, Coral Gables, FL USA; Olga M. Ceron, MD-Novartis, East Hanover, NJ USA.
    File Size: 22 KB
    Retina/Vitreous, Uveitis

    A 43-year-old man with history of ruptured globe of the right eye (OD) from broken glass. Status post-pars plana vitrectomy, secondary iris sutured IOL and subsequent OZURDEX® (dexamethasone intravitreal) implant placement for management of refractory cystoid macular edema (CME), presented for second opinion. Previously on topical: corticosteroids and NSAIDS. On presentation, image highlights migration of implant into the anterior chamber (AC), (A). IOP stable at 16mmHg. Va OD: 20/80. Cornea on clinical exam is clear. Corneal pachymetry was 613ųm. Corneal endothelial cell count: # 974 cells mm2. Ozurdex implant was re-positioned into the posterior chamber using a sinskey hook. Started on pilocarpine and supine position. Implant re-migrated to AC and implant is removed, (B,C). Vison improved to 20/30-2. Patient had improvement of CME on OCT, CSFT of 326ųm. Note: A.Ozurdex in anterior chamber visualized as white linear device in horizontal plane located inferiorly at 6-8 o’clock. B, C: Ozurdex removed